Latest News about XLRN
Recent news which mentions XLRN
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 21, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
December 18, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
December 18, 2020
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
From Benzinga
The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations
December 10, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 09, 2020
From Benzinga
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
From Benzinga
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
October 14, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
October 13, 2020
From Benzinga
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
October 13, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
October 12, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
October 09, 2020
From Benzinga
The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
October 01, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
September 30, 2020
From Benzinga
The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac
September 30, 2020
From Benzinga
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO
September 24, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
September 23, 2020
From Benzinga
Acceleron Pharma Inc (XLRN) Q2 2020 Earnings Call Transcript
August 07, 2020
Tickers
XLRN
From Motley Fool
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
August 06, 2020
From Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
August 02, 2020
From Benzinga
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
July 24, 2020
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
June 23, 2020
From Benzinga
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
May 13, 2020
From Benzinga
Tickers
XLRN
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.